Why the study?
How should low molecular weight heparins be used in special populations such as those with renal dysfunction, obesity, and pregnancy?
Population
Special populations including patients with renal dysfunction, obesity, and pregnancy requiring prevention…
Comparison
Low molecular weight heparins (LMWH) vs Unfractionated heparin (UH)
Design
Review
Authors
Loading...
May guide individualized low-molecular-weight heparin dosing in renal dysfunction, obesity, and pregnancy; leaves open need for prospective validation.
How should low molecular weight heparins be used in special populations such as those with renal dysfunction, obesity, and pregnancy?
This review discusses the pharmacology and usage of low molecular weight heparins in special populations where their use is less clearly defined, such as renal dysfunction, obesity, and pregnancy.
Patricia Howard (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: